SBIR/STTR Research Award
Point-of-care detection for nanoparticle-based sensors
Award amount
$106,732Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- JUNCO LABS, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- DEMFGKMSUKA4
- Solicitation number
- PA10-150
- Topic code
- NIAID
Research abstract
DESCRIPTION (provided by applicant): Although nanomaterials have tremendous potential to improve human health, it has remained surprisingly elusive to leverage their properties to produce real clinical impact. One of the most promising applications of nanoparticles is in sensors for detection of analytes. For sensors that need to be performed at the point of care (POC), one large barrier to unlocking the potential of nanoparticles is the traditional need for complex detectors, such as microscopes, optical filters, charged-coupled detectors, and photomultiplier tubes. While suitable for a well-equipped laboratory, such instrumentation is not feasible in resource-limited settings where some of the most medically dire patients reside. Here, we propose to develop and field-test a novel POC diagnostics device that centers on a signal amplification strategy where silver salts are reduced to solid silver, in a reaction catalyzd by gold nanoparticles conjugated to detection antibodies. In this proposal, we propose todevelop a portable instrument that can read out the resultant optical signal, to help move nanoparticles to being used in real practical POC sensors. PUBLIC HEALTH RELEVANCE: The goal of this grant is to leverage the unique properties of nanoparticles to build a low-cost portable instrument that can read out the optical signals catalyzed by nanoparticles.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients